DocSym
β
Searchsearch
Search
(T48.1) Poisoning: skeletal muscle relaxants [neuromuscular blocking agents]
More details coming soon
179 301 in individuals diagnosis poisoning: skeletal muscle relaxants [neuromuscular blocking agents] confirmed
Diagnosis poisoning: skeletal muscle relaxants [neuromuscular blocking agents] is diagnosed Women are 30.29% more likely than Men
62 493
Men receive the diagnosis poisoning: skeletal muscle relaxants [neuromuscular blocking agents]
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
116 808
Women receive the diagnosis poisoning: skeletal muscle relaxants [neuromuscular blocking agents]
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease poisoning: skeletal muscle relaxants [neuromuscular blocking agents] - Men and Women aged 15-19
In Men diagnosis is most often set at age 0-84
Less common in men the disease occurs at Age 85-95+Less common in women the disease occurs at Age 90-95+
In Women diagnosis is most often set at age 0-89
Disease Features poisoning: skeletal muscle relaxants [neuromuscular blocking agents]
Absence or low individual and public risk
Poisoning: skeletal muscle relaxants [neuromuscular blocking agents] - what does this mean
Neuromuscular blocking agents are drugs that act on the neuromuscular junction to prevent nerve impulses from reaching the muscle, causing paralysis. poisoning occurs when these drugs are taken in excessive amounts, leading to symptoms such as respiratory depression, coma, and even death.
What happens during the disease - poisoning: skeletal muscle relaxants [neuromuscular blocking agents]
The pathogenesis of poisoning due to skeletal muscle relaxants or neuromuscular blocking agents is caused by the inhibition of acetylcholine release at the neuromuscular junction, leading to muscle paralysis and respiratory depression. this can result in decreased oxygen delivery to the tissues, leading to hypoxia and tissue damage, as well as cardiovascular and neurological complications.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging studies such as X-rays, CT scans, or MRI scans
- Electromyography (EMG)
- Nerve conduction studies
- Toxicology screens
Treatment and Medical Assistance
Main goal of the treatment: To reduce the effects of poisoning.
- Administering oxygen
- Administering activated charcoal
- Administering intravenous fluids
- Administering electrolytes
- Administering antidotes
- Administering skeletal muscle relaxants (neuromuscular blocking agents)
- Administering anti-seizure medications
- Administering anti-nausea medications
- Monitoring vital signs
- Providing supportive care
5 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Poisoning: skeletal muscle relaxants [neuromuscular blocking agents] - Prevention
The best way to prevent poisoning from skeletal muscle relaxants is to adhere to the prescribed dosage and to avoid taking any other medications that may interact with the skeletal muscle relaxants. additionally, it is important to keep these medications out of the reach of children and to store them in a secure location.